These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2060886)
21. Chemoprevention of colorectal cancer in ulcerative colitis. Thomson A Intern Med J; 2006 Aug; 36(8):540; author reply 541. PubMed ID: 16866668 [No Abstract] [Full Text] [Related]
22. Colorectal cancer complicating ulcerative colitis: an institutional series. Fracasso P; Assisi D; Stigliano V; Casale V J Exp Clin Cancer Res; 1999 Mar; 18(1):29-32. PubMed ID: 10374673 [TBL] [Abstract][Full Text] [Related]
23. Endoscopic surveillance in ulcerative colitis: smart biopsies do it better. Kiesslich R; Galle PR; Neurath MF Gastroenterology; 2007 Sep; 133(3):742-5. PubMed ID: 17854587 [No Abstract] [Full Text] [Related]
24. Chemoprevention of colorectal cancer in inflammatory bowel disease? A potential role for folate. Mouzas IA; Papavassiliou E; Koutroubakis I Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):421-5. PubMed ID: 9789142 [TBL] [Abstract][Full Text] [Related]
26. Prevention of colorectal cancer: guidelines based on new data. WHO Collaborating Center for the Prevention of Colorectal Cancer. Winawer SJ; St John DJ; Bond JH; Rozen P; Burt RW; Waye JD; Kronborg O; O'Brien MJ; Bishop DT; Kurtz RC Bull World Health Organ; 1995; 73(1):7-10. PubMed ID: 7704928 [TBL] [Abstract][Full Text] [Related]
27. Screening and surveillance of ulcerative colitis. Axon AT Gastrointest Endosc Clin N Am; 1997 Jan; 7(1):129-45. PubMed ID: 8995118 [TBL] [Abstract][Full Text] [Related]
29. The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis. Wolf JM; Rybicki LA; Lashner BA Aliment Pharmacol Ther; 2005 Nov; 22(9):783-8. PubMed ID: 16225486 [TBL] [Abstract][Full Text] [Related]
30. [Ulcerative colitis. Cancer prevention]. Schmiegel W; Pox C; Kroesen A Z Gastroenterol; 2004 Sep; 42(9):1014-8. PubMed ID: 15455276 [No Abstract] [Full Text] [Related]
31. [Arguments against implementing a population-based screening programme for colorectal cancer]. Bonneux L Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1777. PubMed ID: 18754310 [TBL] [Abstract][Full Text] [Related]
32. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Rex DK; Johnson DA; Lieberman DA; Burt RW; Sonnenberg A Am J Gastroenterol; 2000 Apr; 95(4):868-77. PubMed ID: 10763931 [No Abstract] [Full Text] [Related]
34. [Clinical guidelines for the diagnosis and treatment of chronic ulcerative colitis (CUC). Treatment of severe CUC and followup approach for cancer risk assessment]. Rev Gastroenterol Mex; 2007; 72(3):309-19. PubMed ID: 18402224 [No Abstract] [Full Text] [Related]
35. Screening for colorectal cancer. Mandel JS Curr Opin Gen Surg; 1994; ():79-84. PubMed ID: 7584018 [TBL] [Abstract][Full Text] [Related]
36. Review article: the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel disease. Stange EF Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():64-7. PubMed ID: 16961748 [TBL] [Abstract][Full Text] [Related]
37. Cancer biology in ulcerative colitis and potential use in endoscopic surveillance. Shapiro BD; Lashner BA Gastrointest Endosc Clin N Am; 1997 Jul; 7(3):453-68. PubMed ID: 9177146 [TBL] [Abstract][Full Text] [Related]
39. [Colorectal cancer in inflammatory bowel disease]. Henriksen M; Moum B Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2696-9. PubMed ID: 17952155 [TBL] [Abstract][Full Text] [Related]